Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company’s lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by non-circulatory pathways to treat pancreatic cancer.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 111 James Jackson Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://focalmedical.co/
- HQ
- Cary, North Carolina
Focal Medical, Inc. (Acquired By Continuity Biosciences) Questions
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s website is https://focalmedical.co/
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s LinkedIn profile is https://www.linkedin.com/company/focal-medical-inc
Focal Medical, Inc. (Acquired By Continuity Biosciences) has
5 employees.
View email and phone details for 5
employees at Focal Medical, Inc. (Acquired By Continuity Biosciences).
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s industry is
Biotechnology Research
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s top competitors are
Continuity Biosciences, Llc,
Chemical & Biomolecular Engineering At The University Of Delaware,
Diatiro,
Twain Therapeutics,
Blue Current, Inc.,
Vcanbio Cell & Gene Engineering Corporation,
Synchrony Labs,
Advantage Foundry Network, Llc (Afn),
Pinprint,
Carbon.
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s categories are Biotechnology Research
Focal Medical, Inc. (Acquired By Continuity Biosciences)'s founding year is 2015
